AwardTape · Defense awards · Research and development · Science and technology R&D · W81XWH20C0067
W81XWH20C0067: -$212K definitive contract to Bodevet, Inc
Bodevet, Inc holds a definitive contract from Defense Health Agency with -$212K obligated since Oct 2023 and $2.5M obligated over its life, against a ceiling of $2.5M. Latest action Mar 10, 2025.
Clinical trial in support of trauma indications for lyophilized canine blood products
| PIID | W81XWH20C0067 |
|---|---|
| Type | definitive contract |
| Company | Bodevet, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Science and technology R&D |
| PSC | AJ54 LIFE SCIENCES (ENGINEERING) |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | -$212K |
| Total obligated (lifetime) | $2.5M |
| Ceiling (base and all options) | $2.5M |
| Base date | May 1, 2020 |
| Latest action | Mar 10, 2025 |
| End date | Jul 31, 2024 |
| Actions since Oct 2023 | 2 |
| Pricing | Cost plus fixed fee |
| Competition | Not competed |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial